The previous version of this article incorrectly identified the manufacturer of the COVID-19 vaccine. The story has improved. European stocks continued to sell lower on Friday and the uncertainty of the Brexit deal dragged on after Sanofi and GlaxoSmithKline’s COVID-19 vaccine candidate was shocked. U.S. equity futures also stumbled as …
Read More »
Hospitals are scrambling for plans to determine if health care workers can receive the Covid-19 vaccine first, with the expectation of an initial supply of the amount needed to vaccinate all high-priority employees. Enough is expected to deliver the December vaccine to about 200 million people, according to federal officials. …
Read More »
Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts. A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine …
Read More »
Drug development for sickle-cell disease, largely neglected for decades, is becoming a crowded field: two papers published on Saturday in the New England Journal of Medicine give promising results from a study of experimental therapies, including Crisper gene editing for the disease. In addition, Beam Therapeutics Inc. The American Society …
Read More »
Thomas H., president and chief executive of Equity Logic’s Stock Traders Daily. Key Jr. says that while there could be a big price of optimism in the markets, the rest of the year probably won’t see a decline in the big market. But it’s coming in 2021, he tells MarketWatch, …
Read More »